purpose study investigate normal tissue damage caused therapy measured chromosomal aberrations peripheral blood lymphocytes radiotherapy using techniques fluorescence situ hybridization fish chemically induced premature chromosome condensation pcc lung cancer patients treated himac heavy ion medical accelerator chiba entered study signed informed consent frequencies lymphocytes chromosomal aberrations end therapy varied patients frequency significantly correlated radiation field size weakly correlated counts white blood cells lymphocytes treatment result chromosomal aberrations peripheral blood lymphocytes patients treated lung cancer dependent target volume possibly reflecting increased involvement lymph nodes target field carbon ion carbon ion carbon ions